Orilissa Lowers Ovulation Rates But Does Not Seem to Affect Ovaries’ Egg Supply, Phase 1 Trial Shows
News
Orilissa (elagolix), an FDA-approved medication for managing endometriosis pain, lowers ovulation rates in a dose-dependent manner but does not seem to affect the amount of developing eggs in the ovaries ... Read more